Global Hospital-acquired Infection Diagnostics Market Research Report 2024(Status and Outlook)
Report Overview:
The Global Hospital-acquired Infection Diagnostics Market Size was estimated at USD 5205.76 million in 2023 and is projected to reach USD 7426.36 million by 2029, exhibiting a CAGR of 6.10% during the forecast period.
This report provides a deep insight into the global Hospital-acquired Infection Diagnostics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Hospital-acquired Infection Diagnostics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Hospital-acquired Infection Diagnostics market in any manner.
Global Hospital-acquired Infection Diagnostics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott Laboratories
Advan DX
Abbott
Astrazeneca PLC
Bayer Schering Pharma LLC
Becton Dickinson And Company
Cepheid Inc.
Roche AG
Daiichi Sankyo
Hologic, Inc.
Market Segmentation (by Type)
Instrument and Reagents
Consumables
Market Segmentation (by Application)
Hospital
Clinics
Ambulatory Surgery Centers (ASC)
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Hospital-acquired Infection Diagnostics Market
- Overview of the regional outlook of the Hospital-acquired Infection Diagnostics Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hospital-acquired Infection Diagnostics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Hospital-acquired Infection Diagnostics
- 1.2 Key Market Segments
- 1.2.1 Hospital-acquired Infection Diagnostics Segment by Type
- 1.2.2 Hospital-acquired Infection Diagnostics Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Hospital-acquired Infection Diagnostics Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Hospital-acquired Infection Diagnostics Market Size (M USD) Estimates and Forecasts (2019-2030)
- 2.1.2 Global Hospital-acquired Infection Diagnostics Sales Estimates and Forecasts (2019-2030)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Hospital-acquired Infection Diagnostics Market Competitive Landscape
- 3.1 Global Hospital-acquired Infection Diagnostics Sales by Manufacturers (2019-2024)
- 3.2 Global Hospital-acquired Infection Diagnostics Revenue Market Share by Manufacturers (2019-2024)
- 3.3 Hospital-acquired Infection Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4 Global Hospital-acquired Infection Diagnostics Average Price by Manufacturers (2019-2024)
- 3.5 Manufacturers Hospital-acquired Infection Diagnostics Sales Sites, Area Served, Product Type
- 3.6 Hospital-acquired Infection Diagnostics Market Competitive Situation and Trends
- 3.6.1 Hospital-acquired Infection Diagnostics Market Concentration Rate
- 3.6.2 Global 5 and 10 Largest Hospital-acquired Infection Diagnostics Players Market Share by Revenue
- 3.6.3 Mergers & Acquisitions, Expansion
- 4 Hospital-acquired Infection Diagnostics Industry Chain Analysis
- 4.1 Hospital-acquired Infection Diagnostics Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Hospital-acquired Infection Diagnostics Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Market Restraints
- 5.5 Industry News
- 5.5.1 New Product Developments
- 5.5.2 Mergers & Acquisitions
- 5.5.3 Expansions
- 5.5.4 Collaboration/Supply Contracts
- 5.6 Industry Policies
- 6 Hospital-acquired Infection Diagnostics Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Hospital-acquired Infection Diagnostics Sales Market Share by Type (2019-2024)
- 6.3 Global Hospital-acquired Infection Diagnostics Market Size Market Share by Type (2019-2024)
- 6.4 Global Hospital-acquired Infection Diagnostics Price by Type (2019-2024)
- 7 Hospital-acquired Infection Diagnostics Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Hospital-acquired Infection Diagnostics Market Sales by Application (2019-2024)
- 7.3 Global Hospital-acquired Infection Diagnostics Market Size (M USD) by Application (2019-2024)
- 7.4 Global Hospital-acquired Infection Diagnostics Sales Growth Rate by Application (2019-2024)
- 8 Hospital-acquired Infection Diagnostics Market Segmentation by Region
- 8.1 Global Hospital-acquired Infection Diagnostics Sales by Region
- 8.1.1 Global Hospital-acquired Infection Diagnostics Sales by Region
- 8.1.2 Global Hospital-acquired Infection Diagnostics Sales Market Share by Region
- 8.2 North America
- 8.2.1 North America Hospital-acquired Infection Diagnostics Sales by Country
- 8.2.2 U.S.
- 8.2.3 Canada
- 8.2.4 Mexico
- 8.3 Europe
- 8.3.1 Europe Hospital-acquired Infection Diagnostics Sales by Country
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 U.K.
- 8.3.5 Italy
- 8.3.6 Russia
- 8.4 Asia Pacific
- 8.4.1 Asia Pacific Hospital-acquired Infection Diagnostics Sales by Region
- 8.4.2 China
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 India
- 8.4.6 Southeast Asia
- 8.5 South America
- 8.5.1 South America Hospital-acquired Infection Diagnostics Sales by Country
- 8.5.2 Brazil
- 8.5.3 Argentina
- 8.5.4 Columbia
- 8.6 Middle East and Africa
- 8.6.1 Middle East and Africa Hospital-acquired Infection Diagnostics Sales by Region
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Egypt
- 8.6.5 Nigeria
- 8.6.6 South Africa
- 9 Key Companies Profile
- 9.1 Abbott Laboratories
- 9.1.1 Abbott Laboratories Hospital-acquired Infection Diagnostics Basic Information
- 9.1.2 Abbott Laboratories Hospital-acquired Infection Diagnostics Product Overview
- 9.1.3 Abbott Laboratories Hospital-acquired Infection Diagnostics Product Market Performance
- 9.1.4 Abbott Laboratories Business Overview
- 9.1.5 Abbott Laboratories Hospital-acquired Infection Diagnostics SWOT Analysis
- 9.1.6 Abbott Laboratories Recent Developments
- 9.2 Advan DX
- 9.2.1 Advan DX Hospital-acquired Infection Diagnostics Basic Information
- 9.2.2 Advan DX Hospital-acquired Infection Diagnostics Product Overview
- 9.2.3 Advan DX Hospital-acquired Infection Diagnostics Product Market Performance
- 9.2.4 Advan DX Business Overview
- 9.2.5 Advan DX Hospital-acquired Infection Diagnostics SWOT Analysis
- 9.2.6 Advan DX Recent Developments
- 9.3 Abbott
- 9.3.1 Abbott Hospital-acquired Infection Diagnostics Basic Information
- 9.3.2 Abbott Hospital-acquired Infection Diagnostics Product Overview
- 9.3.3 Abbott Hospital-acquired Infection Diagnostics Product Market Performance
- 9.3.4 Abbott Hospital-acquired Infection Diagnostics SWOT Analysis
- 9.3.5 Abbott Business Overview
- 9.3.6 Abbott Recent Developments
- 9.4 Astrazeneca PLC
- 9.4.1 Astrazeneca PLC Hospital-acquired Infection Diagnostics Basic Information
- 9.4.2 Astrazeneca PLC Hospital-acquired Infection Diagnostics Product Overview
- 9.4.3 Astrazeneca PLC Hospital-acquired Infection Diagnostics Product Market Performance
- 9.4.4 Astrazeneca PLC Business Overview
- 9.4.5 Astrazeneca PLC Recent Developments
- 9.5 Bayer Schering Pharma LLC
- 9.5.1 Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Basic Information
- 9.5.2 Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Product Overview
- 9.5.3 Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Product Market Performance
- 9.5.4 Bayer Schering Pharma LLC Business Overview
- 9.5.5 Bayer Schering Pharma LLC Recent Developments
- 9.6 Becton Dickinson And Company
- 9.6.1 Becton Dickinson And Company Hospital-acquired Infection Diagnostics Basic Information
- 9.6.2 Becton Dickinson And Company Hospital-acquired Infection Diagnostics Product Overview
- 9.6.3 Becton Dickinson And Company Hospital-acquired Infection Diagnostics Product Market Performance
- 9.6.4 Becton Dickinson And Company Business Overview
- 9.6.5 Becton Dickinson And Company Recent Developments
- 9.7 Cepheid Inc.
- 9.7.1 Cepheid Inc. Hospital-acquired Infection Diagnostics Basic Information
- 9.7.2 Cepheid Inc. Hospital-acquired Infection Diagnostics Product Overview
- 9.7.3 Cepheid Inc. Hospital-acquired Infection Diagnostics Product Market Performance
- 9.7.4 Cepheid Inc. Business Overview
- 9.7.5 Cepheid Inc. Recent Developments
- 9.8 Roche AG
- 9.8.1 Roche AG Hospital-acquired Infection Diagnostics Basic Information
- 9.8.2 Roche AG Hospital-acquired Infection Diagnostics Product Overview
- 9.8.3 Roche AG Hospital-acquired Infection Diagnostics Product Market Performance
- 9.8.4 Roche AG Business Overview
- 9.8.5 Roche AG Recent Developments
- 9.9 Daiichi Sankyo
- 9.9.1 Daiichi Sankyo Hospital-acquired Infection Diagnostics Basic Information
- 9.9.2 Daiichi Sankyo Hospital-acquired Infection Diagnostics Product Overview
- 9.9.3 Daiichi Sankyo Hospital-acquired Infection Diagnostics Product Market Performance
- 9.9.4 Daiichi Sankyo Business Overview
- 9.9.5 Daiichi Sankyo Recent Developments
- 9.10 Hologic, Inc.
- 9.10.1 Hologic, Inc. Hospital-acquired Infection Diagnostics Basic Information
- 9.10.2 Hologic, Inc. Hospital-acquired Infection Diagnostics Product Overview
- 9.10.3 Hologic, Inc. Hospital-acquired Infection Diagnostics Product Market Performance
- 9.10.4 Hologic, Inc. Business Overview
- 9.10.5 Hologic, Inc. Recent Developments
- 10 Hospital-acquired Infection Diagnostics Market Forecast by Region
- 10.1 Global Hospital-acquired Infection Diagnostics Market Size Forecast
- 10.2 Global Hospital-acquired Infection Diagnostics Market Forecast by Region
- 10.2.1 North America Market Size Forecast by Country
- 10.2.2 Europe Hospital-acquired Infection Diagnostics Market Size Forecast by Country
- 10.2.3 Asia Pacific Hospital-acquired Infection Diagnostics Market Size Forecast by Region
- 10.2.4 South America Hospital-acquired Infection Diagnostics Market Size Forecast by Country
- 10.2.5 Middle East and Africa Forecasted Consumption of Hospital-acquired Infection Diagnostics by Country
- 11 Forecast Market by Type and by Application (2025-2030)
- 11.1 Global Hospital-acquired Infection Diagnostics Market Forecast by Type (2025-2030)
- 11.1.1 Global Forecasted Sales of Hospital-acquired Infection Diagnostics by Type (2025-2030)
- 11.1.2 Global Hospital-acquired Infection Diagnostics Market Size Forecast by Type (2025-2030)
- 11.1.3 Global Forecasted Price of Hospital-acquired Infection Diagnostics by Type (2025-2030)
- 11.2 Global Hospital-acquired Infection Diagnostics Market Forecast by Application (2025-2030)
- 11.2.1 Global Hospital-acquired Infection Diagnostics Sales (K Units) Forecast by Application
- 11.2.2 Global Hospital-acquired Infection Diagnostics Market Size (M USD) Forecast by Application (2025-2030)
- 12 Conclusion and Key Findings
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook